Dyne Therapeutics Statistics

Total Valuation

DYN has a market cap or net worth of $2.24 billion. The enterprise value is $1.81 billion.

Market Cap	2.24B
Enterprise Value	1.81B

Important Dates

The last earnings date was Thursday, May 2, 2024, after market close.

Earnings Date	May 2, 2024
Ex-Dividend Date	n/a

Share Statistics

DYN has 81.11 million shares outstanding. The number of shares has increased by 43.88% in one year.

Shares Outstanding	81.11M
Shares Change (YoY)	+43.88%
Shares Change (QoQ)	+31.97%
Owned by Insiders (%)	0.55%
Owned by Institutions (%)	112.00%
Float	61.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.69
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 21.83, with a Debt / Equity ratio of 0.06.

Current Ratio	21.83
Quick Ratio	n/a
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -110.90% and return on invested capital (ROIC) is -52.68%.

Return on Equity (ROE)	-110.90%
Return on Assets (ROA)	-90.00%
Return on Capital (ROIC)	-52.68%
Revenue Per Employee	n/a
Profits Per Employee	-$2.09M
Employee Count	123
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +103.98% in the last 52 weeks. The beta is 1.00, so DYN's price volatility has been similar to the market average.

Beta (1Y)	1.00
52-Week Price Change	+103.98%
50-Day Moving Average	26.51
200-Day Moving Average	16.72
Relative Strength Index (RSI)	56.91
Average Volume (30 Days)	1,237,787

Short Selling Information

The latest short interest is 9.63 million, so 11.88% of the outstanding shares have been sold short.

Short Interest	9.63M
Short Previous Month	9.02M
Short % of Shares Out	11.88%
Short % of Float	15.60%
Short Ratio (days to cover)	11.31

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-265.85M
Pretax Income	-257.40M
Net Income	-257.40M
EBITDA	-255.00M
EBIT	-257.40M
Earnings Per Share (EPS)	-$3.97

Full Income Statement

Balance Sheet

The company has $455.47 million in cash and $26.62 million in debt, giving a net cash position of $428.85 million or $5.29 per share.

Cash & Cash Equivalents	455.47M
Total Debt	26.62M
Net Cash	428.85M
Net Cash Per Share	$5.29
Equity / Book Value	478.06M
Book Value Per Share	5.89
Working Capital	465.78M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$219.79 million and capital expenditures -$690,000, giving a free cash flow of -$220.48 million.

Operating Cash Flow	-219.79M
Capital Expenditures	-690,000
Free Cash Flow	-220.48M
FCF Per Share	-$2.72

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DYN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-43.88%
Shareholder Yield	-43.88%
Earnings Yield	-11.47%
FCF Yield	-9.83%

Analyst Forecast

The average price target for DYN is $37.67, which is 36.09% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$37.67
Price Target Difference	36.09%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3